Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
7,628,992
-
Share change
-
-2,278,780
-
Total reported value
-
$10,371,000
-
Price per share
-
$1.36
-
Number of holders
-
33
-
Value change
-
-$3,091,435
-
Number of buys
-
9
-
Number of sells
-
16
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2016
As of 30 Jun 2016,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,628,992 shares.
The largest 10 holders included
Frigate Ventures LP, Vivo Capital, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Ancora Advisors, LLC, BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, Connor, Clark & Lunn Investment Management Ltd., FMR LLC, and WASATCH ADVISORS INC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.